Guía OncoSur de cáncer de mama

>  99 Tratamiento sistémico del cáncer de mama 6. Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013;31:65. 7. Bachelot T, Romieu G, Campone M, Diéras V, Cropet C, Dalenc F, et al. Lapatinib plus capecitabine in patients with previously untreated brain metastases from HER2-positive metastatic breast cancer (LANDSCAPE): a single-group phase 2 study. Lancet Oncol. 2013;14:64. 8. Manejo y tratamiento de crisis epilépticas en pacientes con tumores cerebrales y cánceres. GEIMO. Disponible en: https://www.geino.es/privado/guias/ManejoCrisisEpilepticas.pdf 9. Madhup R, Kirti S, Bhatt ML, Srivastava PK, Srivastava M, Kumar S, et al. Letrozole for brain and scalp metastases from breast cancer-a case report. Breast. 2006;15:440. 10. Petrelli F, Ghidini M, Lonati V, Tomasello G, Borgonovo K, Ghilardi M, et al. The efficacy of lapatinib and capecitabine in HER-2 positive breast cancer with brain metastases: A systematic review and pooled analysis. Eur J Cancer. 2017;84:141.

RkJQdWJsaXNoZXIy MTQzMjMwMg==